KATY GARNER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PULASKI, TN NPI 1821330424

General Payments — all program years on this page

$1,865.68

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $394.93 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $394.9321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $549.9932
2022 $356.9918
2023 $563.7729
2024 $394.9321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104209531 AstraZeneca Pharmaceuticals LP $16.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104467444 AstraZeneca Pharmaceuticals LP $13.53 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104754948 AstraZeneca Pharmaceuticals LP $17.23 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104773424 AstraZeneca Pharmaceuticals LP $17.17 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105243224 AstraZeneca Pharmaceuticals LP $16.00 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105588032 AstraZeneca Pharmaceuticals LP $14.90 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105774214 AstraZeneca Pharmaceuticals LP $13.53 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107151776 ABBVIE INC. $21.67 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107151778 ABBVIE INC. $20.73 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107151780 ABBVIE INC. $23.23 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107151782 ABBVIE INC. $18.31 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116652261 GlaxoSmithKline, LLC. $17.00 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130948058 PFIZER INC. $15.08 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131628561 PFIZER INC. $19.00 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133340570 Alkermes, Inc. $20.26 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943830 Vanda Pharmaceuticals Inc. $29.37 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943832 Vanda Pharmaceuticals Inc. $34.22 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133943834 Vanda Pharmaceuticals Inc. $15.16 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134958281 Exact Sciences Corporation $19.88 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144631001 Xeris Pharmaceuticals, Inc. $17.65 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147287498 Mylan Specialty L.P. $15.01 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.